$13.01
$-1.39 (-9.65%)
End-of-day quote: 05/17/2024
NasdaqGS:NVAX
Novavax Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | NYSE | Outperform | $154.64 | $174.55 | 0.00% | 3 | $371.30B |
| MRK | Merck | NYSE | Outperform | $131.19 | $130.51 | 0.00% | 11 | $331.49B |
| AZN | AstraZeneca PLC | LSE | Outperform | £121.10 | £165.99 | 0.00% | 16 | £188.60B |
| PFE | Pfizer | NYSE | Outperform | $28.64 | $32.87 | 0.00% | 6 | $163.88B |
| GSK | GSK | LSE | Outperform | £17.75 | £17.30 | 0.00% | 12 | £72.73B |
| MRNA | Moderna | NasdaqGS | Outperform | $132.90 | $135.42 | 0.00% | 1 | $50.85B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.13k | ¥4.74k | 0.00% | 0 | ¥6.49T |
| BNTX | BioNTech | NasdaqGS | Outperform | $90.61 | $123.75 | 0.00% | 3 | $22.41B |
| DVAX | Dynavax Technologies | NasdaqGS | Outperform | $11.11 | $25.00 | 0.00% | 1 | $1.52B |
| VBIV | VBI Vaccines | NasdaqCM | Outperform | $0.63 | $6.00 | 0.00% | 0 | $18.27M |
